<DOC>
	<DOCNO>NCT00700921</DOCNO>
	<brief_summary>This study test whether lovastatin help modify lung inflammation patient COPD ( Chronic Obstructive Pulmonary Disease ) .</brief_summary>
	<brief_title>Lovastatin Potential Modulator Apoptosis Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description>The impact lovastatin , 40mg mouth daily biological clinical outcome evaluate exploratory 16-week comparative treatment efficacy trial 44 adult former smoker establish COPD moderate severity . This trial employ longitudinal randomize , parallel-arm , double-blind , placebo-controlled design use biomarkers airway inflammation primary outcome interest .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Lovastatin</mesh_term>
	<mesh_term>L 647318</mesh_term>
	<mesh_term>Dihydromevinolin</mesh_term>
	<criteria>1 . Adult ( ≥45 year ) former smoker ≥ 10 packyears cigarette smoke 2 . FEV1/FVC ratio &lt; 70 % 3 . Postbronchodilator FEV1 50 % 80 % predict undergoing bronchoscopy , 30 % 80 % predict undergoing induced sputum 4 . DLco/VA &lt; 80 % predict 5 . Ability perform adhere study protocol 6. ability provide inform consent . 1 . Asthma comorbid lung disease , 2 . Hypoxemia ( PaO2 &lt; 55 mmHg SpO2 &lt; 88 % room air ) , undergo bronchoscopy 3 . Exacerbation COPD within last 6 week 4 . Upper low respiratory tract infection within last 6 week 5 . Current smoking 6 . Significant coronary artery disease reflect unstable angina , myocardial infarction angioplasty/stenting/bypass surgery within 6 month 7 . Current use HMGcoAreductase inhibitor 8 . Current use inhale corticosteroid 9 . Concurrent use Cyp3A4 ( isoform cytochrome P450 ) inhibitors 10 . History adverse reaction HMGcoAreductase inhibitor ( rhabdomyolysis , hepatitis ) 11 . For patient undergo bronchoscopy , contraindication fiberoptic bronchoscopy conscious sedation , include abnormality platelet count , prothrombin time partial thromboplastin time .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>